Events

Q2 Interim Report FY22/23

SEB Healthcare Seminar 2022

Stora Aktiedagen Stockholm 28 November 2022

Redeye Life Science Day 2022 – 24 November 2022

Biovica Company Presentation - 23 November 2022

Redeye Diagnostics Forum – 28 September 2022

CEO Presentation at ABGSC Investor Day – 13 September 2022

Redeye Late Stage Life Science companies – CEO presentation and interview 2 September 2022

CEO interview by Redeye 1 September 2022

CEO presentation AGM 31 August 2022

Market update, 18 August 2022

ABGSC Life Science Summit, 19 May 2022

Capital Markets Day, 17 May 2022

ABGSC Investor Day, 8 December 2021

CEO’s presentation Annual General Meeting 2021

Company presentation August 2020

Interview with CEO Anders Rylander

Interview with CEO Anders Rylander

Company presentation May 2020

Capital Market Day 11th of May 2020

Nordnet Nordic Invest, Capital Markets Seminar, 6 mars 2020

Aktiedagen Lund 28 januari

Panelsamtal: Framtidens behandling av cancer på Aktiedagen 28 januari i Lund

Pareto Securities life science analytiker går igenom Biovica

Audiocast, December 6, 2019. Q2 Interim Report

Audiocast, September 19, 2019. Update on clinical development progress

Pareto Securities’ 10th Annual Health Care Conference in Stockholm 5th September 2019

Interview with Anders Rylander, CEO

Management presentation directed issue April 2019

Web-cast telephone conference, at 09:00 am CET, March 21

The live webcast and a recorded on-demand version including the presentation material will be accessible at:

https://financialhearings.com/event/11802

Börsveckans Småbolagsdag 19 februari 2019 – intervju

Börsveckans Småbolagsdag 19 februari 2019 – presentation

Biovica Stora Aktiedagen i Lund 2019-01-29

RedEye LifeScience Dag den 21 november 2018

Some of our Collaborations

>3200

Numbers of patients in studies

24

Publications

10

Pharma Contracts